Big Un Limited (ASX:BIG, or ‘the Company’) is pleased to announce the release of its 4E preliminary results for the year ended 30 June 2017. BIG achieved cashflow positivity for the year, driven by $21.5m in cash receipts from customers and other sources (up 429% from FY16). BIG generated a $4.2m cash surplus from operating activities (FY16 $3.6m cash deficit). It is the Company’s policy to adopt a conservative approach to revenue recognition and recognise accounting revenue over the membership period resulting in a substantial increase in deferred revenues to $9.4m (FY16 $1.7m) which will be released over FY18.
BIG achieved accounting revenues for the year of $14.0m (up 429% from FY16) and a net loss of $4.2m for FY17, a significant improvement from the FY16 loss of $7.8m. This was a result of a strong improvement in gross margin to 27.4% (from a negative gross margin in 2016 of 33%).
Therefore, for the year ended 30 June 2017 the revenue recognised for accounting purposes is $9.4m lower than the actual cash collected. The consequence of this conservative revenue recognition treatment is that the cash surplus of $4.2m is reduced to an accounting net loss of $4.2m. In conclusion, the company’s business operations are healthy with a strong and growing operating cash margin.
- Forums
- ASX - By Stock
- BIG
- Ann: 2017 Financial Year Results Commentary
Ann: 2017 Financial Year Results Commentary, page-2
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online